Prostate Cancer: Screening
Description of Resource:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer in men age 70 and older. This is a D recommendation, which means the USPSTF recommends against the service because there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits. For men ages 55 to 69, the decision about PSA–based screening should be an individual one. This is a C recommendation, which means the USPSTF recommends selectively offering or providing this service to individual patients based on professional judgment and patient preferences because there is at least moderate certainty that the net benefit is small.